U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07353320) titled 'Probiotics Regulate Intestinal Health and Alleviate Anxiety' on Dec. 25, 2025.
Brief Summary: This study is a randomized, double-blind, placebo-controlled trial aimed primarily at investigating the effects of Weizmannia coagulans BC99 on alleviating anxiety and depression and the gut microbiota.
Study Start Date: April 10, 2024
Study Type: INTERVENTIONAL
Condition:
Anxiety Depression
Intervention:
DIETARY_SUPPLEMENT: probiotics group
The intervention lasted 8 weeks, with follow-ups at weeks 0 and 12.
DIETARY_SUPPLEMENT: Placebo Group
The intervention lasted 8 weeks, with follow-ups at weeks 0 and 12.
Recruitment Status: CO...